In early 2026, ICON PLC disclosed a preliminary overstatement of revenues for 2023 and 2024, launched an Audit Committee–led internal review of its accounting practices, and postponed its Q4 and ...

ICON PLC faces a critical test Monday when the contract research organization finally releases long-delayed fourth-quarter and full-year 2025 results, two months after an accounting investigation sent ...

Icon Plc ICLR shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing internal ...

Investigation’s preliminary indications are that 2023 and 2024 revenue may have been overstated by less than 2% for each fiscal year ICON plc, (NASDAQ: ICLR) today announced that it intends to release ...

Investing.com - Rothschild Redburn downgraded ICON plc (NASDAQ:ICLR) to Neutral from Buy and lowered its price target to $100 from $226 following the company’s announcement of an internal accounting ...

Icon's stock plummeted about 40% on Feb. 12, as the firm announced an accounting investigation initiated by the Audit Committee of Icon's board of directors. Preliminary results indicate the company's ...